Literature DB >> 34773617

Designing PCR Primers for the Amplification-Refractory Mutation System.

Majid Komijani1, Khashayar Shahin2, Esam Ibraheem Azhar3, Mohammad Bahram4,5.   

Abstract

The recent development in genetic research indicates that there exists intraspecific genetic variability in many organism groups. These variations, which result in a variety of genotypes and phenotypes within a population, are called polymorphism. Mutations in different ways can alter the organism's phenotype and affect its fitness, for example, by altering disease susceptibility or resistance. Therefore, the detection of point mutations in different genes of a population is of particular importance. The amplification-refractory mutation system technique is a PCR-based method to detect single nucleotide polymorphisms in the genome. The high repeatability, low cost, high accessibility, and no need for sophisticated technology are the main advantages of the ARMS-PCR technique, compared with other available methods such as PCR-RFLP. This chapter describes the design and analysis method of primers for the ARMS-PCR technique.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ARMS-PCR; Molecular biology; Primer design

Mesh:

Substances:

Year:  2022        PMID: 34773617     DOI: 10.1007/978-1-0716-1799-1_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Guidelines for the tetra-primer ARMS-PCR technique development.

Authors:  Ruan Felipe Vieira Medrano; Camila Andréa de Oliveira
Journal:  Mol Biotechnol       Date:  2014-07       Impact factor: 2.695

  1 in total
  2 in total

1.  Tetra-Primer Amplification-Refractory Mutation System (ARMS)-PCR for Genotyping Mouse Leptin Gene Mutation.

Authors:  Jiangang Chen; Xinyun Xu; Paul Dalhaimer; Ling Zhao
Journal:  Animals (Basel)       Date:  2022-10-05       Impact factor: 3.231

2.  Case report: Durable response to alectinib in ALK-rearranged lung adenocarcinoma with acquired, crizotinib-resistant ALK C1156F mutation.

Authors:  Chuangzhou Rao; Liangqin Nie; Xiaokang Wu; Xiaobo Miao; Ting Chen; Liuxi Chen; Dongqing Zhang; Quan Lin
Journal:  Front Oncol       Date:  2022-09-20       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.